Marijan Šitum

ORCID: 0000-0003-4077-2059
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Urinary Tract Infections Management
  • Esophageal Cancer Research and Treatment
  • Gestational Trophoblastic Disease Studies
  • Gut microbiota and health
  • Viral-associated cancers and disorders
  • Pregnancy and preeclampsia studies
  • Bacterial Infections and Vaccines
  • Maternal and fetal healthcare
  • Streptococcal Infections and Treatments
  • Urinary Bladder and Prostate Research
  • Pneumonia and Respiratory Infections

University of Split
2021-2025

The gold standard for treating high-risk non-muscle-invasive bladder cancer involves the transurethral removal of cancerous tissue followed by BCG immunotherapy. So far, there is no reliable biomarker predicting efficacy and identifying patients who will or not respond to treatment. Emerging evidence suggests that urinary microbiota may play a crucial role in efficacy. This study aimed explore (i) changes during six induction cycles (ii) its potential predictive determining outcome To this...

10.3389/fcimb.2025.1479795 article EN cc-by Frontiers in Cellular and Infection Microbiology 2025-03-10

Abstract Background This study aimed to present the characteristics and outcomes of benign urinary bladder masses, as well patients diagnosed with such lesions. Methods A single-center, cross-sectional, retrospective was conducted. The involved who underwent transurethral resection primary tumor over a four-year period (May 2017–2021) were subsequently lesion. Results Out 478 tumor, 26 (5.4%) most common lesion urothelial papilloma (50%, 13 patients). majority men (76.9%) had history smoking...

10.1186/s12301-023-00382-2 article EN cc-by African Journal of Urology 2023-09-30

This study investigated the impact of initial clinical presentation bladder cancer on tumor characteristics. A cross-sectional, retrospective was performed, and it involved 515 patients who underwent transurethral resection at University Hospital Center Split between April 2019 2023, excluding recurrent cases. The association symptomatic versus asymptomatic characteristics analyzed. subgroup analysis compared with gross microscopic hematuria. Multiple regression analyses revealed a...

10.3390/jcm12134259 article EN Journal of Clinical Medicine 2023-06-25

To examine the relationship between clinical patient characteristics and severity of disease course in patients hospitalized due to urinary bladder tamponade. The was assessed based on hemoglobin (Hgb) levels upon admission, requirement for red blood cell transfusion (RBCT), length hospital stay.

10.4103/ua.ua_70_23 article EN cc-by-nc-sa Urology Annals 2024-07-01

The aim of this article was to investigate the impact chronic antithrombotic therapy (AT) use on time detection bladder cancer, assuming that patients taking AT experience episodes macroscopic hematuria earlier, and therefore have a more favorable histopathological grade stage, as well smaller number size tumors compared not AT.A retrospective, cross-sectional study conducted, including 247 who underwent cancer surgery for first at our institution during three-year period (2019-2021)...

10.5173/ceju.2022.193 article EN Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication 2022-01-01
Coming Soon ...